NCT00124072
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine
See it on ClinicalTrials.gov ↗12,064 people
17%
83%
2,052 womenmiddle line = equal numbers10,012 men
- Phase
- PHASE3
- Paid for by
- University of Oxford
- Finished
- 2008-05
- Health conditions
- Cardiovascular Disease
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 64.2 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Chronic liver disease”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“No other predominant medical problem (other than coronary heart disease \[CHD\]) which might limit compliance with 5 years of study treatment”
Study titles and rules are shown in their original English.